We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information and guidance on a range of medical devices for users and patients.
Actions that trial sponsors should consider to build resilience into clinical trial design
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information for companies on the import and export of controlled drugs to and from the UK.
Find out how to import timber and wood material, including the documents, identity checks and plant health inspections required.
How to apply for a licence to modify or remove dams, burrows and lodges at any time of year.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Details of sediment and sample analysis for marine licence applications.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
List of Field Safety Notices from 26 February to 1 March 2024
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
How the maritime industry should treat waste at sea and in ports, reduce oil and air pollution, and control ozone-depleting substances.
Controlled chemicals, drug precursor chemicals and hazardous chemicals.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Information on road traffic devices, such as breath-testing, speed cameras and immobilisation devices.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Batch recall alert for human eye gels that may be prescribed by vets and used under the cascade.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.